NASDAQ:CGIX
Delisted
Cancer Genetics Stock News
$1.08
+0 (+0%)
At Close: May 27, 2022
Introducing Cancer Genetics (NASDAQ:CGIX), The Stock That Collapsed 98%
10:29am, Thursday, 14'th Nov 2019
Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. For example, we sympathize with...
Cancer Genetics, Inc. Announces Strategic Transactions
08:15pm, Thursday, 24'th Oct 2019
Cancer Genetics, Inc. (CGIX), a leader in proprietary preclinical test systems supporting drug discovery and development at early stages, valued by the pharmaceutical industry, biotechnology companies
Cancer Genetics Announces 1-for-30 Reverse Stock Split
12:30pm, Thursday, 24'th Oct 2019
Cancer Genetics, Inc. (CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced that it will effect a 1-for-30 reverse stock split of its outstanding co
32 Healthcare Stocks Moving In Friday's Pre-Market Session
12:00am, Friday, 18'th Oct 2019Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners
10:55am, Thursday, 17'th Oct 2019
Interpace Diagnostics Group, Inc. (IDXG) announced today that it has closed on a $13 million Convertible Preferred Stock investment by Ampersand Capital Partners (Ampersand). This investment constitu
